David Lederer is an accomplished drug developer and former academic expert in pulmonary fibrosis and lung transplantation. Currently serving as the Executive Medical Director for Genetic Medicines at Regeneron, they oversee early clinical development programs while leading cross-functional teams. Previously, Lederer held notable roles at Columbia University, mentoring junior faculty in pulmonary research, and served as Senior Medical Advisor at the Pulmonary Fibrosis Foundation. They have authored over 200 peer-reviewed publications and contributed significantly to the field as a key opinion leader in idiopathic pulmonary fibrosis and lung transplantation.
This person is not in the org chart
This person is not in any teams
This person is not in any offices